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Abstract
Caspase proteases are a conserved protein family predominantly known for engaging and executing apoptotic cell death.
Nevertheless, in higher eukaryotes, caspases also influence a variety of cell behaviors including differentiation, proliferation
and growth control. S. cerevisiae expresses a primordial caspase, yca1, and exhibits apoptosis-like death under certain
stresses; however, the benefit of a dedicated death program to single cell organisms is controversial. In the absence of a
clear rationale to justify the evolutionary retention of a death only pathway, we hypothesize that yca1 also influences non-
apoptotic events. We report that genetic ablation and/or catalytic inactivation of Yca1p leads to a longer G1/S transition
accompanied by slower growth in fermentation conditions. Downregulation of Yca1p proteolytic activity also results in
failure to arrest during nocodazole treatment, indicating that Yca1p participates in the G2/M mitotic checkpoint. 20s
proteasome activity and ROS staining of the Dyca1 strain is indistinguishable from its isogenic control suggesting that
putative regulation of the oxidative stress response by Yca1p does not instigate the cell cycle phenotype. Our results
demonstrate multiple non-death roles for yca1 in the cell cycle.
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Introduction
The timely and organized form of programmed cell death
known as apoptosis has vital functions in the development and
pathologies of complex metazoan life forms. Apoptosis is regulated
by conserved signaling pathways that activate caspase proteases
leading to target protein cleavage and cell death. Morphological
features typical of apoptosis have been recognized in single cell
organisms and structural homologues of the caspase family
(metacaspases) have been identified [1–3]. Metacaspase proteases
have since been characterized as apoptotic regulators in plants,
fungi and protozoa supporting the concept of a widely conserved
cell death pathway [4,5].
A single metacaspase, YOR197w, was identified in the genome
of S. cerevisiae and named Yeast Caspase 1, (Yca1p also known as
MCA1). Yca1p demonstrates enzymatic peptidase activity analo-
gous to mammalian caspase activity, and is inhibited in the
presence of the fluoromethyl ketone (FMK) conjugated caspase-
inhibitory substrate z-VAD-FMK [4]. In addition to canonical
caspase substrate specificity Yca1p has secondary substrate
specificity directed at arginine-lysine motifs [5]. Furthermore,
Yca1p-mediated apoptosis has been observed in a variety of
apoptogenic situations including senescence and following insults
such as hydrogen peroxide (H2O2) and acetic acid [4,6–9]. These
findings have promoted the view of yeast as an evolutionarily
distant model of metazoan apoptosis and numerous orthologous
pathways have since been reported.
Despite the discovery of homologues to apoptotic proteins in
yeast, there was limited consensus that yeast engaged a death
program similar to that of multi-cellular metazoans. Arguments to
rationalize apoptosis in yeast have included altruism in the
presence of reactive oxygen species or killer toxins, a program to
execute cells that fail to mate in response to pheromone and a
mechanism for lateral gene transfer [6,10–12]. In addition, the
apoptotic pathway in yeast has been suggested to act as a
mechanism to protect surrounding cells from the potentially
damaging cellular constituents of dead or dying cells [13].
However, the validity of these hypotheses has yet to be fully
explored and may not justify the development and retention of a
biochemical pathway devoted solely to cell death. Without an
incontrovertible justification for an apoptotic response in yeast, it is
also reasonable to conjecture that proteins such as Yca1p may
have initially developed or co-evolved other vital non-death
functions [14,15].
Caspase activity is an inductive signal for non-death functions
such as cell cycle progression, proliferation, cell migration and
differentiation in mammalian cell lines [14,16]. Enzymatic
processing of target proteins by caspase-3 at key time points
promotes differentiation in mammalian precursor and progenitor
cells [15,17]. The enzymatic activity of caspases has also been
associated with the proper activation and release from the mitotic
checkpoint. In HeLa cells, disruption of microtubule dynamics
results in caspase mediated cleavage of the mitotic checkpoint
protein BubR1p, augmenting the duration of mitosis [18].
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causes the failure of metaphase arrest in the presence of
microtubule depolymerizing nocodazole [19]. Various apopto-
genic insults can promote death at specific phases in the cell cycle
indicating that the cell-cycle and apoptosis are intimately linked
[20]. Apoptosis of G2/M arrested cells is a widespread observation
in the literature [21]. Finally, caspase-8 is activated in EGF-
stimulated primary hepatocytes and participates in mitogenic
signaling as a positive regulator of G1/S transition [22].
Collectively these findings suggest that a non-death role for
caspases in the mammalian cell cycle exists and, depending on the
system/conditions, can modulate the fidelity of major cell cycle
checkpoints.
In this study we describe a non-death role for the yeast
metacaspase Yca1p. DNA content analysis of Dyca1 vs. wild-type
shows that Yca1p accelerates G1/S and antagonizes G2/M
transitions granting Yca1p-expressing cells an increased fitness in
fermentive conditions. Analysis of a Yca1p catalytic inactivation
mutant revealed that enzymatic activity of Yca1p is upstream of
the G1/S transition phenotype. The slow growth phenotype of the
Dyca1 strain was exacerbated in the presence of the catalytic
inactivation mutant resulting in an even longer procession through
the S and G2/M cell cycle phases. Furthermore, genetic or
chemical inhibition of Yca1p results in desensitization to
nocodazole. These findings support the hypothesis that the
canonical apoptotic proteins also regulate critical non-death
functions in single cell organisms.
Results and Discussion
Ablation of yca1 alters DNA content profiles
Mammalian caspase activity can alter cell cycle timing when
observed under specific conditions. As a preliminary query to
investigate a cell cycle role for Yca1p, we examined the
Saccharomyces Genome Database (www.yeastgenome.org) for
cell cycle specific changes in yca1 expression [23]. The CDC15
synchronization time-course presented a marked peak of yca1
expression at a time following the second G1/S transition post
release from growth-repressive conditions (Figure S1, t=150 min).
The single surge of yca1 expression at the second G1/S transition
may have been related to a phenomenon whereby a fraction of
daughter cells in synchronized cultures do not separate from the
mother cells until the second division after release from arrest [24].
This observation suggested a link between Yca1p and G1/S
associated cell cycle dynamics. DNA content of wild-type BY4741
and Yca1p disrupted (Dyca1) yeast strains were quantified to
examine this hypothesis. Strains were grown to mid-exponential
phase and DNA content was analyzed by flow cytometry (see
Figure S2 for example distributions, gating and controls). Our first
experiments performed in standard YPD media exhibited no
observable changes between the wild-type and mutant strains (data
not shown).
Yeast is an adaptive organism that survives in a variety of
environments by modulating protein expression and activity, such as
during the fermentation phase [25] where the natural habitat of the
yeast is commonly the acidic surrounding of a fruit or within its
confines. Given that fermentive growth may be more typical of
yeast’s natural environment, the experiment was repeated in
acidified media. Wild-type BY4741 cells displayed no discernable
change in DNA distribution between acidic and neutral media.
However, Dyca1 grown in acidic media consistently exhibited a
substantial increase in the proportion of G1 cells (1-copy of DNA)
and aproportionate decreaseinG2/Mphasecells(2-copiesofDNA)
when compared with wild-type controls in the same media (Fig. 1 a,
b). From this we conclude that genetic ablation of yca1 promotes a
shift in the equilibrium between the 1-copy (G1) and 2-copy (G2/M)
DNA populations of yeast during fermentative growth.
Enzymatic activity of Yca1p promotes the G1/S transition
and increases the robustness of log-phase yeast
Enzymatic inactivation of Yca1p via mutation of the catalytic
cysteine at position 297 to alanine has been described [4]. To
examine whether the enzymatic activity of Yca1p influenced cell
cycle progression/equilibrium, the yca1-C297A mutant was
constructed and expressed under its endogenous promoter with
the selectable trophic marker leu2 in the Dyca1 background strain
(Figure S3). The resulting mutant strain (referred to henceforth as
C297A) and a control strain consisting of only the selectable
marker leu2 in the yca1 locus of the same background strain
(referred to as the LEU2 strain) were used. In all cell cycle
Figure 1. Cell cycle profiles during logarithmic growth. Representative DNA content profiles for exponentially growing (a) BY4741 and (b)
Dyca1 cells. The percentage of cells in the 1-copy and 2-copy gated regions is indicative of the percentage of cells in the respective G1 and G2/M
phases of the cell cycle.
doi:10.1371/journal.pone.0002956.g001
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strain indicating that the selectable marker did not influence cell
cycle behavior (unpublished observation). Furthermore, reverse
transcriptase PCR was used to test if modifications to yca1 affect
the expression of the genes that flank the yca1 locus. It was
observed that expression of the flanking bfr1 and lip5 genes were
unaltered in the Dyca1 and the C297A strains in comparison to
BY4741 (Figure S4) indicating that the disruptions were specific to
yca1.
Samples were collected at multiple time points during mid-log
growth and DNA content was analyzed (see Figure S2 for example
time course). The percentage of cells in each gate were quantified
and averaged for all samples over the indicated time points. The
averages of biological replicates were compared for the different
strains and summarized as pie charts (Fig. 2 a). The doubling time
of the exponentially growing cultures was then calculated based on
optical density measurements. We observed that both the Dyca1
and C297A strains had a protracted progression through the cell
cycle suggesting that endogenous expression of Yca1p improves
robustness of yeast cells in fermentive conditions (Fig. 2 b). The
actual time spent in each phase of the cell cycle was derived by
multiplying the percentage of cells in a particular phase by the
observed doubling time (Fig. 2 c). One-way ANOVA confirmed
significant variation of the mean within the group of different
strains for each observed phase of the cell cycle (G1, S and G2/M;
P,0.01). During exponential growth the time required for Dyca1
cells to pass from G1 to S is significantly extended, passage
through G2/M is accelerated and the S-phase was relatively
unaffected when compared to BY4741 (Fig. 2 c). The C297A
strain displayed a comparable delay through the G1/S transition
just as the Dyca1 strain suggesting that timely G1/S transition is
dependent on the enzymatic activity of Yca1p. The time required
for the C297A strain to pass through G2/M was comparable to
that of BY4741 implying that the accelerated transition through
G2/M observed for the Dyca1 could be corrected by replacement
of Yca1p without regard to its proteolytic activity. Interestingly,
the C297A strain also demonstrated a protracted progression
through S phase when compared to both the BY4741 and Dyca1
strains. It is not immediately apparent how the C297A strain could
alter S phase when the comparable knockout strain did not yield a
similar effect. However, the substantial delay of the doubling time
observed in the C297A strain suggests that YCA1-C297Ap may be
acting in a dominant inhibitory fashion, interacting with the
Yca1p targets and limiting their respective activity. Such an
interaction could convey an illusory correction of the G2/M
timing phenotype that is observed. Together, these results clearly
implicate a role for the yeast metacaspase protein in a cell cycle
timing function, modulating both G1/S and G2/M progression.
Yca1p activity is required for appropriate activation of
the nocodazole induced G2/M checkpoint
Enzymatic activity of Caspase-3 in human hepatoma cells has
been identified as a requirement for appropriate cell cycle arrest in
response to nocodazole [19]. The observation that the G2/M
timing was accelerated in the absence of the yeast caspase (Fig. 2 c)
led us to hypothesize that Yca1p may perform a similar function.
The following experiments were performed to test if Yca1p
similarly affected the G2/M checkpoint.. When cells were treated
with 15 ug/mL nocodazole in YPD media, exponentially growing
BY4741 and Dyca1 strains were predominantly arrested in G2
within 100 minutes (data not shown). BY4741 cells similarly
treated in acidified media were observed to respond more slowly
but did reach a primarily G2 arrested state within 180 min (Fig. 3
a). Intriguingly, the Dyca1 cells were desensitized to the arresting
agent in acidified media. Only a marginal increase in the size of
the G2 population was observed (Fig. 3 b), suggesting that loss of
Yca1p causes the cells to bypass the G2/M check point and
continue the cell cycle proper (Fig. 3 c, d).
To test whether or not the G2/M defect derived from the
enzymatic activity associated with Yca1p, BY4741 cells were pre-
treated with the pan-caspase inhibitor z-VAD-FMK before the
addition of nocodazole. The characteristic increase in the G2/M
population and decrease in the G1/S population were eliminated
in the presence of the caspase inhibitor. This result paralleled the
response of the C297A strain to nocodazole in identical conditions,
indicating that the enzymatic activity of Yca1p is required for the
nocodazole response (Fig 4 a). Protease activity analogous to
mammalian caspases 6 and 8 has been observed in yeast
responding to H2O2 [4]. Caspase 6 and 8 specific peptide
inhibitors were tested for their capacity to inhibit cell cycle arrest
in response to nocodazole (Fig. 4 b). The response to both
inhibitors was similar to that observed with the C297A strain and
Figure 2. Derivation of the duration of cell cycle phases. (a)
BY4741 (wild-type), Dyca1 and C297A catalytic inactivation mutant were
grown to mid-logarithmic phase in acidic YPD media. Cells were
collected at regular intervals over multiple time courses and analyzed
by flow cytometry. Results shown indicate the percentage of cells found
in the different phases of the cell cycle. (b) Doubling time of
exponentially growing cells in YPD pH 3.5 media. (c) Time spent in
specific phases of cell cycle derived by multiplying the doubling time
and the phase population. (* P#0.05 heteroscedastic unpaired 2-tailed
t-test, 6SEM for all).
doi:10.1371/journal.pone.0002956.g002
A Non-Death Role for YCA1
PLoS ONE | www.plosone.org 3 August 2008 | Volume 3 | Issue 8 | e2956zVAD treatment, however, BY4741 cells responded with greater
sensitivity to the caspase 8 inhibitor in comparison to the -6
inhibitor. To verify that the results of these experiments were not
skewed by the presence of cell death in response to nocodazole
[18,26] the sub-G1 populations of both BY4741 and Dyca1 cells
were quantified (Fig. 4 c). Only a very small proportion of cells
died in response to nocodazole (,2%). As such, the additional cell
death in BY4741 (,1% of cells) may be explained as an apoptotic
response to nocodazole activated Yca1p. We conclude that the
nocodazole induced G2/M checkpoint is dependent on the
enzymatic activity of Yca1p.
The cell cycle phenotype is not caused by excessive
oxidative stress
We sought to identify proteins that could modify the G1/S
checkpoint in response to yca1 by using comparative proteomics.
Whole cell lysates derived from BY4741 and Dyca1 were resolved
by 2D SDS-PAGE (Fig. 5) and examined for altered mobility in
response to yca1ablation. We observed numerous changes to the
yeast proteome between gels; particularly a number of protein
species unique to Dyca1 strain that were not apparent in protein
lysates from the BY4741 strain. These spots were excised and
analyzed by MS (Table 1). The list of yca1 enriched/responsive
proteins included mitochondria-associated factors and proteins
functioning in the oxidative stress response, the 20s proteasome
and nucleotide excision repair (NER) process.
Increased oxidative damage and compensatory activity of the
20s proteasome occurs in the absence of Yca1p [7]. As such, we
reasoned that altered expression of mitochondrial, stress response
and DNA repair proteins might reflect the presence of oxidative
DNA damage which might be responsible for the extended G1/S
transition in the Dyca1 strain. We assessed intracellular reactive
oxygen species (ROS) via bivariate flow cytometry using
dihydrorhodamine 123 (DHR123) as an indicator of ROS and
propidium iodide (PI) as a marker of membrane integrity/viability
[27]. When treated with 3mM H2O2 for 2 hours before analysis,
BY4741 cells were observed to be predominantly ROS positive
with a smaller percentage of non-viable PI positive cells co-staining
with DHR123. Untreated exponentially growing BY4741 and
Dyca1 cells, however, were largely negative for both PI and
DHR123 (Fig. 6 a). We also assessed the chymotrypsin-like activity
of the 20s proteasome in BY4741 and Dyca1 cell lysates (Fig. 6 b).
We did not observe any change between the BY4741 and
Dyca1strains which indicated that the 20s proteasome was not
abnormally activated. These results suggest that the cell cycle
effects and proteomic changes seen in Dyca1 cells are not due to
oxidative stress or abnormal proteasome activity.
We identified Rad23p as a potential yca1 modulated protein.
Rad23p stabilizes DNA damage repair machinery (G1 checkpoint)
and is a cofactor to the ubiquitin/proteasome pathway [28].
Increased expression of Rad23p in the Dyca1 strain was confirmed
by western blot (Fig. 6 c). Rad23p is usually degraded at the G1/S
transition [28]. Given the preponderance of G1 cells in the Dyca1
strain, the increased presence of Rad23p in these cells suggests the
potential activation and stabilization of the NER associated
checkpoint [29]. We examined the possibility of direct interaction
between Yca1p and Rad23p; however, we were unable to
Figure 3. Response of cells to nocodazole. DNA content profile of wild-type (a) BY4741 and (b) Dyca1 cells over time after treatment with 15ug/
mL nocodazole. Relative change in population between nocodazole treated and untreated (c) BY4741 and (d) Dyca1 cells. For each phase the value
represents the difference between population of nocodazole treated and untreated cells (value=treated–untreated). (N=3, 6S.E.M. for all).
doi:10.1371/journal.pone.0002956.g003
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Rad23p with the Yca1p-TAP strain or Yca1p with the Rad23p-
TAP strain (unpublished observations). The lack of Rad23p
cleavage products in the western blots in addition to the failure to
co-immunoprecipitate suggests that the Rad23p response is
secondary to Yca1p activity. However, the increase in Rad23p
in the Dyca1 strain might suggest the occurrence of alternate DNA
processing events which may contribute to the G1/S phenotype.
Low-level ROS has been reported to act as a proliferative
signal, stimulating G1/S progression [30,31]. We cannot discount
the possibility that retention of Rad23p and the G1/S transition
phenotype result from subtle differences in ROS levels that are not
detectable by our methods. However, the absence of 20s
proteasome activity and ROS staining suggest that oxidative
stress-associated DNA damage is not directly invoking an NER
response in Dyca1 cells. In fermentive conditions, both strains grow
in a healthy manner free of excessive oxidative stress or cell death
suggesting that these are not the direct causes of the cell cycle
phenotype.
In conclusion, our results demonstrate a previously unrecog-
nized role for the yeast metacaspase Yca1p in cell cycle
progression. Yca1p accelerates the G1/S transition and slows
the G2/M transition. In the first instance Yca1p confers a growth
advantage by promoting the transition between G1 and S phase.
Secondly, our results show that Yca1p antagonizes cell growth by
limiting the G2/M transition. Furthermore, we observed that
Dyca1 and Yca1p inhibited cells are similarly desensitized to the
nocodazole induced G2/M checkpoint. Reduced response to
nocodazole has been detected in mammalian systems in which the
Yca1p related enzyme caspase-3 is inhibited. Based on these
observations, we speculate that the disparate ability of metacas-
pases to both promote and antagonize different cell cycle
checkpoints may represent an early form of the proliferation/
differentiation regulating activity exhibited by metazoan caspases.
Materials and Methods
Yeast strains and growth conditions
S. cerevisiae strains used in this study include wild-type haploid
BY4741 (MATa his3D1 leu2D0 met15D0 ura3D0) and the
knockout Dyca1 strain from the BY4741 background (Open
Biosystems, Huntsville, AL). Yeast cultures were grown in yeast
extract peptone dextrose (YPD) medium (2% glucose, 2% Bacto
peptone, and 1% yeast extract; pH adjusted to 3.5 with HCL; agar
was added for solid plates to a final concentration of 2%).
Overnight starter cultures grown from a single S. cerevisiae colony
were used to inoculate large YPD cultures to a final optical density
(OD660) of 0.05. These cultures were grown at 30u C with 250
RPM orbital rotation into mid-logarithmic phase at which point
samples were collected as described in the Exponential growth, caspase
inhibition and cell cycle arrest section below.
Construction of the C297A strain
The YCA1 open reading frame in the BG1805 plasmid (Open
Biosystems, Huntsville, AL.) was used as a template for site
directed mutagenesis. A mutagenic fragment was generated using
a mutagenic primer 59-TGTTTGACTCTGCTCATTCGGG-
TAC-39 and a reverse primer with a flanking HindIII site 59-
GGGAAGCTTCTACATAATAAATTGCAGAT-3. The 487 bp
mutagenic fragment was then used in a second PCR reaction with
a primer directed at the 59 end of yca1 59-GGGGGATCCAT-
GAAGATGAGCCTCGAAGT-39 with a flanking BamH1 site.
We cloned the C297A construct into the BamH1/HindIII site of
the pSSB08 plasmid; obtained by introducing two silent mutations
Figure 4. G2/M response of caspase inhibited cells. (a) G2/M
content of C297A caspase catalytic inactivation mutant or wild-type
BY4741 cells pre-treated for 30 minutes with 20 mM pan-caspase
inhibitor z-VAD-FMK in response to 15 mg/mL nocodazole. (b) BY4741
cells pre-treated for 30 minutes with 20 mM Caspase 6 (z-VEID-FMK) and
caspase 8 (z-IETD-FMK) specific peptide inhibitors before exposure to
15 mg/mL nocodazole. (c) Sub G1 population of BY4741 and Dyca1 cells
either untreated or exposed to 15 mg/mL nocodazole over time (N=3,
6S.E.M., P#0.05 heteroscedastic unpaired 2-tailed t-test between
paired *, " and { symbols; note Figure 4a is a composite of multiple
experiments).
doi:10.1371/journal.pone.0002956.g004
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the Leu2 selection marker of the pRS405 backbone [32] created
by Simon St-Pierre. The construct was amplified using primers
containing 41-mer regionsofhomology to the endogenous yca1locus
and 20-mers directed at the construct 59-CTATTGAAAAAGCA-
TGGCTTCGCATTAATAGGAGCCAAAAATATGAAGATG-
AGCCTCGAAG-39 and 59-CTATTGAAAAAGCATGGCTTC-
GCATTAATAGGAGCCAAAAATCCCCGGGCTGCAGGAA-
TTCGA-39.T h eDyca1 strain was transformed with the double
stranded DNA product using a standard LiAC/SS carrier DNA/
PEG method.
Protein extraction
S. cerevisiae cells were pelleted, washed twice and resuspended in
500 mL of ice cold modified RIPA buffer (50 mM Tris-HCL, 1%
NP-40, 150mM NaCl 1mM EDTA 1% Glycerol) containing
protease inhibitors. 0.7g of acid washed glass beads (Sigma
Aldrich, Ontario, Canada) were added and cells were lysed with a
Disruptor Genie (Scientific Industries, New York, USA) at 4uC.
Lysates were clarified by centrifugation at 50006g for 20 minutes
and the soluble fraction was retained for analysis.
Exponential growth, caspase inhibition and cell cycle
arrest
For exponential growth experiments BY4741, Dyca1 or C297A
strains were grown to OD660 of 0.4–0.5 at which point optical
density was recorded and aliquots were collected at regular
intervals. To inhibit endogenous caspase-like enzymatic activity
cells were pretreated with 20 mM of either z-VAD-FMK, z-VEID-
FMK or z-IETD-FMK (BioVision, Mountain View, CA) at an
OD660 of 0.3. Cultures were allowed to grow in the presence of
inhibitor for an additional 45 minutes before further treatment
with 15 mg/mL nocodazole (Sigma, Saint Louis, MO) and
subsequent time course sample collection. For cell cycle arrest,
BY4741, Dyca1 or C297A cells were grown to OD660 of 0.4–0.5
before addition of 15 mg/mL nocodazole. In all cases, OD660
Figure 5. Representative 2D gels of BY4741 and Dyca1 proteomes. (a) BY4741 and (b) Dyca1 cells separated along pH 4-7 IPG strips. The
BY4741 gels were relatively over-stained to expose yca1 inducible protein species in the Dyca1 gel. Arrowheads depict spots that appear unique to
Dyca1 lysates. Alphanumeric designation corresponds with identities summarized in table 1.
doi:10.1371/journal.pone.0002956.g005
Table 1. MS identification of protein species induced by yca1 ablation.
Spot Name Score/peptides Notes
a
C1 PST2 72/2 Mitochondrial; Oxidative stress response protein induced by YAP1
C3 MRP8 52/2 Putative mitochondrial ribosomal protein
C4 PUP2 73/3 Alpha subunit of 20S proteasome
C5 LIA1 171/5 deoxyhypusine hydroxylase; Possible role in mitochondrial positioning
C6 SGT2 151/5 Similarity to human SGT which negatively regulates HSP70
C7 PEP4 155/4 Aspartate protease involved in metabolic degradation (pepsin like); important for
protein turnover after oxidative damage
C8 TIF2 347/9 eIF4a homolog
C10 PYK1 90/5 Pyruvate kinase
C11 RAD23 181/4 Nucleotide excision repair; DNA damage checkpoint role normally degraded during
G1/S transition
C12 PDI1 227/7 Protein disulfide isomerase involved in formation and management of scrambled
protein disulfide bonds
aNotes derived from ORF descriptions available at www.yeastgenome.org.
doi:10.1371/journal.pone.0002956.t001
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3 hours. Collected samples were immediately fixed in cold 70%
ethanol and stored at 4uC overnight before further analysis.
Optical density at 660 nm (OD660) of liquid yeast culture was
determined using an Ultrospec 2100 PRO spectrophotometer.
DNA staining
3.5610
6 cells were collected from ethanol fixed samples, washed
with 50 mM sodium citrate and resuspended in sodium citrate
containing 0.2 mg/mL RNase A (GE Healthcare, Pittsburgh, PA).
Samples were incubated at 37uC for 22 hours to promote hydrolysis
of endogenous RNA. Sytox green (Molecular Probes, Burlington,
Ontario) was added to a final concentration of 3.75 mM and samples
were incubated in the dark at room temperature for 1 hour. Finally,
samples were pelleted and resuspended in PBS before analysis by
flow cytometry. DakoCytomation Summit version 4.0 software was
usedtogateandquantifycellsafterflowacquisition(seeFigureS2for
example gating).
Flow cytometry
Flow cytometry data acquisition was performed with a Coulter
MoFlo (Fullerton, California, USA), all samples were excited by a
488 nmSpectra-Physics Argonlaser,Sytoxgreendyeand DHR123
fluorescence was detected with a 530/40 bandpass filter. PI was
detected with a 630/30 bandpass filter. 50000 cells per sample were
counted. Dual compensation was performed to remove signal bleed
between the PI and DHR123 channels. Flow data was analyzed
with DakoCytomation Summit version 4.0 software.
2D gel electrophoresis
Samples were diluted in isoelectric focusing buffer (7M urea,
2M thiourea, 4% CHAPS, 1% DTT) and absorbed into 17 cm
ReadyStrip
TM IPG strips (Biorad) following the manufacturer’s
directions. Isoelectric focusing was performed on a Protean
IEF Cell (Biorad) with the following program: 200 V for 1 hour,
500 V for 1 hour, 5000 V ramp for 5 hours, 5000 V for 80000
VH. For the second dimension, IPG strips were overlaid onto 10%
SDS-PAGE gels and electrophoresed in a Protean II apparatus
(Biorad).
Mass spectrometry
Silver stain and in-gel digest were performed using a standard
method [33]. Sample cleanup was performed using ZipTip
(Millipore). Tandem mass spectra were collected on an Applied
Biosystems/SciEX QSTAR XL with oMALDI2 ion source.
Spectra were analyzed using Mascot 2.0 (Matrix Science, UK)
Figure 6. Downstream effects and oxidative stress. (a) Bivariate flow cytometry analysis of H2O2 treated BY4741, BY4741 and Dyca1 cells dual
stained with propidium iodide (PI) and ROS stain dihydrorhodamine 123 (DHR123). (N=3, 6SEM). (b) 20s proteasome activity from BY4741 and
Dyca1 lysates (N=3, 6SEM). (c) Western blot for 3 biological replicates of BY4741, Dyca and Drad23 (100 mg protein for each). Drad23 appears as a
negative control. The Rad23p antibody was obtained from Santa Cruz Biotechnology (SCBT, Santa Cruz, CA), b-tubulin (Iowa State University
Hybridoma Bank) was used as a loading control.
doi:10.1371/journal.pone.0002956.g006
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20070306). MS/MS tolerance was 60.4 Da.
20s Proteasome activity assay
50 mg of clarified whole cell extract was analyzed using the
Proteasome Activity Kit (Chemicon, California, USA). Fluorescent
AMC liberated from the 20s proteasome substrate suc-LLVY-
AMC was detected for 90 minutes at 37uC as per instructions on a
Fluoroskan Ascent FL microplate fluorometer (Thermo Scientific,
USA) with excitation at 380nm and emission at 460 nm.
Supplementary Information
Figure S1 shows expression pattern of Yca1p following release
from CDC15 synchronization. Figure S2 displays G1 and G2/M
gating controls in addition to example gating as used for time
course DNA profiles. Figure S3 depicts the verification of the
C297A strain. Figure S4 demonstrates the invariability of the
genes immediately flanking the YOR197w open reading frame.
Supporting Information
Figure S1 Expression of yca1 after cdc15 synchronization.
Adaptation of data from Spellman et al. (Mol Biol Cell 9, 3273-97
1998) depicting expression of YCA1 after CDC15 synchroniza-
tion. Arrows denote the first observation of new buds. Peak
expression after 150 minutes release coincides with second
appearance of small buds indicative of the G1/S transition in
budding yeast.
Found at: doi:10.1371/journal.pone.0002956.s001 (0.10 MB
DOC)
Figure S2 DNA staining and flow cytometry gates. (a) 636
phase contrast/FITC microscope merge of sytox green stained
yeast cells arrested with nocodazole. Microscopy was performed
on an Axioplan 2 compound microscope fitted with a Zeiss
Axiocam. Fixed cells were suspended in 50mM sodium citrate,
slide mounted and viewed at 636 magnification with a
PlanApochromat 1.4 NA objective lens at 22uC. Phase contrast
and FITC channel images were merged using Axiovision 3.1
software (Carl Zeiss, Toronto Canada). (b) Control DNA content
profile demonstrating gating used to quantify cell cycle populations
for nocodazole treated BY4741 cells. The histogram abscissa
represents relative fluorescent intensity of fixed cells incubated
with the nucleic acid stain Sytox green. (c,d) Example of gating
used to identify G1 and G2 peaks. Cells were arrested at the G1/S
transition with (c) the ribonucleotide reductase inhibitor Hydroxy-
urea or in the G2/M phase with (d) Nocodazole. (e) Example time
response (in minutes) and gating of wild type BY4741 cells to
15 mg/mL nocodazole. The montage demonstrates a progressive
decay of the G1 population concurrent with an enlargement of the
G2 population consistent with G2 arrest.
Found at: doi:10.1371/journal.pone.0002956.s002 (0.60 MB
DOC)
Figure S3 Verification of integration, deletion and expression.
Integration of the C297A construct into the Dyca1 background
strain. (a,b) The location of integration and expression of
integrants were verified using A–B and C–D primers designed
for the systematic deletion project (http://www-sequence.stanford.
edu/group/yeast_deletion_project/confirmation.html) predicted
663 bp and 2.7 kb fragments were observed. (c) Reverse
transcriptase PCR confirming the presence of the C297A
transcript. ADH3 was used as a loading control.
Found at: doi:10.1371/journal.pone.0002956.s003 (0.42 MB
DOC)
Figure S4 Expression of yca1 flanking genes. a) Region of
chromosome XV depicting genes flanking yca1. b) Reverse
transcriptase PCR of flanking genes demonstrates invariable
expression in the Dyca1 and C297A strains when compared to
the congenic BY4741 background strain. ADH3 was used as a
loading control.
Found at: doi:10.1371/journal.pone.0002956.s004 (0.20 MB
DOC)
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